Using cancer biomarkers, the VENTANA MMR RxDx Panel helps determine which tumor patients may benefit from GSK immunotherapy
The drug aims to treat patients with myelodysplastic syndromes
The authorization enables emergency use of Actemra/RoActemra for the treatment of COVID-19 in hospitalized adult and pediatric patients
The test will be widely available to individuals through pharmacies and other locations in accordance with local guidelines and testing strategies
First commercial test will enable expedited coronavirus testing to meet urgent medical needs
